Companies: 10,795·Total market cap: $144.5T
Kane Biotech Inc.

Kane Biotech Inc.

KNE.VTSXVHealthcare● Active
$0.04
+$0.01(+16.67%)
Market Cap$6364995
P/E Ratio—
52W High$0.07
52W Low$0.03
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Kane Biotech Inc.（KNE.V）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KNE.V · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.01kne.v eps ttm · kne.v earnings per shareEarnings history
PE Ratio (TTM)—kne.v pe ratio ttm · kne.v price to earningsPE Ratio deep dive
Revenue (TTM)58574.00kne.v revenue ttm · kne.v annual revenueFull revenue history
Dividend Yield不分红does kne.v pay dividends · kne.v dividend yieldDividend history
Shares Outstanding162.2Mkne.v shares outstanding · kne.v floatShares outstanding history
Next EarningsTBAkne.v earnings date · kne.v next earningsEarnings history

探索 Kane Biotech Inc. 数据

kne.v stock data · financials
市值$6.4Mkne.v market cap · kne.v valuation
分析师预测—
股息不分红does kane biotech inc. pay dividends · kne.v dividend yield
营收$427869-79.44%kane biotech inc. annual revenue · kne.v revenue
盈利EPS $-0.02+25.66%kne.v earnings · kne.v eps
市盈率—kne.v pe ratio · kne.v price to earnings

财务快照

完整财报
FY 2025Revenue$427869.00▼ 79.44% YoY
202320242025
kane biotech inc. revenue · kne.v revenue 2025
FY 2025Net Income-$2.7M▲ +10.03% YoY
202320242025
kane biotech inc. net income · kne.v profit 2025
FY 2025EPS$-0.02▲ +25.66% YoY
202320242025
kne.v eps · kane biotech inc. earnings per share 2025
TTM:Revenue: $58574.00Net Income: -$2.2MEPS: $-0.01View income statement →

股票表现

完整历史
1D+16.67%
1W+0.00%
1M+0.00%
3M+0.00%
YTD-12.50%
1Y-41.67%
5Y-81.58%

关于 Kane Biotech Inc.

CEORobert Huizinga
IPO DateOct 1, 2003
Employees32
CountryCA
Websitekanebiotech.com

Kane Biotech Inc. Headquartered in Winnipeg, Canada, Kane Biotech Inc. is a biotechnology firm established in 2001, focusing on the research, development, and global commercialization of innovative technologies and pro…

BiotechnologyHealthcareTSXVCA

what is kane biotech inc. · kne.v stock overview · kane biotech inc. company profile · who is kane biotech inc. ceo · kne.v TSXV · kane biotech inc. headquarters · kane biotech inc. business segments

关于股票概览与关键数据

Kane Biotech Inc.（KNE.V）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 1, 2003 在 TSXV 上市。截至最近交易日，KNE.V 股价为 $0.04，市值约为 $6.4M。过去12个月累计回报 -41.67%，年初至今回报 -12.50%。

2025 财年 Kane Biotech Inc. 营收 $427869.00。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Kane Biotech Inc.（KNE.V）股价为 $0.04，在 TSXV 上市，52周区间为 $0.03 – $0.07。

KNE.V 最新股价KNE.V quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议